Latest News and Press Releases

PK Study Successfully Demonstrates that Fingerprint Sweat Provides Reliable Sample for Drug Detection FDA 510(k) Clearance Would Enable the Introduction of INBS’ Technology to the US in 2025 NEW...

Quarterly revenue increased 10% year-on-year and 20% quarter-on-quarter, marking four consecutive quarters of year-on-year growth Higher-margin, recurring cartridge revenue surpassed reader revenue...

Intelligent Bio Solutions has partnered with B2i Digital to execute an investor communications program.

Unaudited quarterly revenue increased 10% year-on-year and 20% quarter-on-quarter Higher-margin, recurring cartridge revenue expected to surpass reader revenue as primary...

INBS announces one year of enhanced workplace safety with Mount Anvil following the integration of fingerprint drug testing.

NEW YORK, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company offering non-invasive, rapid testing solutions,...

INBS announces its distribution partnership with Spirit Group, an Australian, Indigenous-owned marketing and consulting agency.

INBS announces the addition of GPS Marine, a leading provider of marine construction and logistics services, to its growing number of customer accounts.

INBS successfully completes in-clinic testing proposed to the FDA earlier this year in its clinical study plan.

NEW YORK, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing...